Not applicableStudy completedNCT03091764What this trial is testingEvaluation of a Patient-Reported Symptom Index for NMIBCWho this might be right forSuperficial Bladder Cancer University of Sydney 498
Large-scale testing (Phase 3)Active Not RecruitingNCT05714202What this trial is testingTAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)Who this might be right forBladder Cancer Janssen Research & Development, LLC 1,135
Not applicableEnded earlyNCT04412070What this trial is testingAssessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC PatientsWho this might be right forBladder Cancer Hopital Foch 20
Not applicableStudy completedNCT06126796What this trial is testingUrine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)Who this might be right forNon-muscle Invasive Bladder Cancer Mayo Clinic 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823What this trial is testingClinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder CancerWho this might be right forNon-muscle Invasive Bladder Cancer (NMIBC) ImmunityBio, Inc. 20
Large-scale testing (Phase 3)Looking for participantsNCT07804056What this trial is testingInvestigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder CancerWho this might be right forUrinary Bladder NeoplasmsNon-muscle Invasive Bladder Cancer (NMIBC) Hamlet Pharma AB 194
Early research (Phase 1)Study completedNCT01498172What this trial is testingBCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) PatientsWho this might be right forBladder Cancer Patrice Jichlinski 23
Testing effectiveness (Phase 2)Looking for participantsNCT03945162What this trial is testingIntravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") PatientsWho this might be right forNon-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07800507What this trial is testingTrop2-Targeted Near-Infrared Fluorescence Imaging-Guided Precise Resection of Non-Muscle Invasive Bladder CancerWho this might be right forNMIBC Yunnan Cancer Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777848What this trial is testingEvaluate the Efficacy and Safety of RAG-01 as Monotherapy and in Combination With Chemotherapy in Patients With Non-muscle Invasive Bladder Cancer (NMIBC).Who this might be right forNon-muscle Invasive Bladder Cancer (NMIBC) Ractigen Therapeutics. 114
Early research (Phase 1)Study completedNCT05085990What this trial is testingSafety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)Who this might be right forNon-muscle Invasive Bladder Cancer Protara Therapeutics 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07189793What this trial is testingToripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 StudyWho this might be right forUrinary Bladder NeoplasmsCarcinoma, Transitional CellCarcinoma in Situ of Bladder+1 more First Affiliated Hospital of Wenzhou Medical University 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT04706598What this trial is testingSafety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG TreatmentWho this might be right forUrinary Bladder NeoplasmsImmunotherapy Fudan University 25
Large-scale testing (Phase 3)UnknownNCT04490993What this trial is testingSafety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) PatientsWho this might be right forNon-muscle Invasive Bladder Cancer Jiangsu Yahong Meditech Co., Ltd aka Asieris 359
Early research (Phase 1)UnknownNCT04819399What this trial is testingInvestigation of Safety and Tolerability of Catumaxomab in Patients With NMIBCWho this might be right forUrinary Bladder Neoplasms Lindis Biotech GmbH 30
Testing effectiveness (Phase 2)Ended earlyNCT03167151What this trial is testingPembrolizumab in Intermediate Risk Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)Who this might be right forNon-muscle Invasive Bladder Cancer (NMIBC) University of Oxford 6
Testing effectiveness (Phase 2)Study completedNCT02015104What this trial is testingStudy of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCGWho this might be right forBladder Cancer National Cancer Institute (NCI) 32
Not applicableStudy completedNCT02252549What this trial is testingAn International Randomized Study to Compare SPIES Versus WLIWho this might be right forBladder Cancer Clinical Research Office of the Endourological Society 700
Early research (Phase 1)Study completedNCT03191578What this trial is testingImmunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI®Who this might be right forHigh-Risk Non-Muscle-Invasive Bladder Cancer Archivel Farma S.L. 44
Post-approval studies (Phase 4)Not Yet RecruitingNCT06548438What this trial is testingThe Impact of PDD During TURB for NMIBCWho this might be right forBladder Cancer A.O.U. Città della Salute e della Scienza 300